A uniform activated B-cell–like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases-Reference-Cited by-同舟云学术

A uniform activated B-cell–like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases

Published:2005-12-22 Issue:1 Volume:107 Page:190-196
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:Blood

Author:

Camilleri-Broët Sophie,Crinière Emmanuelle,Broët Philippe,Delwail Vincent,Mokhtari Karima,Moreau Anne,Kujas Michèle,Raphaël Martine,Iraqi Wafae,Sautès-Fridman Catherine,Colombat Philippe,Hoang-Xuan Khê,Martin Antoine

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Reference34 articles.

1. Jaffe ES, Harris NL, Vardiman JW, et al. Pathology and Genetics: Neoplasms of the Hematopoietic and Lymphoid Tissues. In: Kleihues P and Sobin L, eds. World Health Organization Classification of Tumours. Lyon, France: IARC Press; 2002; 171-173.

2. Primary Central Nervous System Lymphomas in 72 Immunocompetent Patients: Pathologic Findings and Clinical Correlations

3. Decreasing incidence rates of primary central nervous system lymphoma

4. Diffuse large cell lymphoma

5. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

Cited by 308 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Bruton tyrosine kinase inhibitor-resistance gene signature predicts prognosis and identifies TRIP13 as a potential therapeutic target in diffuse large B-cell lymphoma;Scientific Reports;2024-09-11

2. ACT001 inhibits primary central nervous system lymphoma tumor growth by enhancing the anti-tumor effect of T cells;Biomedicine & Pharmacotherapy;2024-09

3. Bruton's Tyrosine Kinase Inhibitors in Refractory or Relapsing Primary Central Nervous System Lymphoma: A Meta-analysis and Systematic Review;World Neurosurgery;2024-08

4. The Molecular Landscape of Primary CNS Lymphomas (PCNSLs) in Children and Young Adults;Cancers;2024-04-29

5. Targets and treatments in primary CNS lymphoma;Leukemia & Lymphoma;2024-04-24